Non-surgical interventions for treating pelvic organ prolapse in women: results of a component network meta-analysis

Johnson E1, Kenny R1, Oliver A1, Still M1, Wallace S1, Gravenhorst K2, Bugge C3, Dwyer L4, Spencer S5, Freeborn C5, Igualada-Martinez P6, Thakar R7, Guerrero K8, Vale L9

Research Type

Pure and Applied Science / Translational

Abstract Category

Pelvic Organ Prolapse

Abstract 320
POP, Incontinence and Imaging 2
Scientific Podium Short Oral Session 33
Friday 9th October 2026
16:52 - 17:00
Parallel Hall 3
Pelvic Organ Prolapse Conservative Treatment Female Pelvic Floor
1. Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK, 2. Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK, 3. School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK, 4. Saint Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Hathersage Road, Manchester, UK, 5. Expert by experience, UK, 6. Department of Health Sciences, College of Health, Medicine and Life Sciences, Brunel University London, UK, 7. Croydon Health Services NHS Trust, Croydon, Surrey, UK, 8. NHS Greater Glasgow & Clyde, Glasgow, UK, 9. Global Heath Economics Centre & Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK
Presenter
Links

Abstract

Hypothesis / aims of study
To assess the effectiveness and adverse events of non-surgical interventions for treating pelvic organ prolapse (POP) in women.
Study design, materials and methods
A systematic review with a unique component network meta-analysis (CNMA); the review was preregistered on PROSPERO (CRD42024595871). The Cochrane Incontinence Specialised Register, including randomised controlled trials (RCTs) and quasi-RCTs from MEDLINE, CINAHL, Embase and CENTRAL, and clinical trial registries, was searched from inception to 31 March 2023. The search strategies used to maintain the Cochrane Incontinence Specialised Register were applied to search each database and registry independently, up to 24 April 2025. Iterative reference list and citation checking were undertaken. Ten women with lived experience of POP were involved in defining the scope and eligibility criteria, as well as interpreting the results. The eligibility criteria included RCTs and quasi-RCTs of women with POP assessing the effects of non-surgical interventions compared with no treatment, usual care, another non-surgical intervention, or surgery. Women with lived experience of POP and clinical experts defined the outcomes of interest to the review: quality of life; subjective cure or improvement of POP; activities of daily living (ADLs); objective cure or improvement in POP; and adverse events.

Study selection, data extraction and critical appraisal were undertaken using gold standard methods outlined by the Cochrane Handbook. Pairs of reviewers independently screened abstracts and full-texts for potentially relevant records. Two independent reviewers undertook data extraction using a pre-piloted form and critically appraised each study using Cochrane’s Risk of Bias 2.0 tool. Frequentist CNMAs were conducted to assess the effectiveness of individual intervention components. Where CNMA was considered unsuitable due to heterogeneity, narrative syntheses were undertaken using Synthesis Without Meta-analysis (SWiM) guidance. Two independent reviewers used the Confidence in Network Meta-Analysis (CINeMA) tool and an adapted version of the grading of recommendations assessment, development, and evaluation (GRADE) approach for narrative syntheses to assess the certainty of evidence for each outcome.
Results
Fifty-three studies (with 9442 participants) were eligible. Pelvic floor muscle training (PFMT) alone was the component most often assessed (n = 18 studies). Most studies were at high risk of bias for each outcome assessed. Conducting a CNMA was feasible for three of the five outcomes of interest: quality of life; subjective cure or improvement in POP; and objective cure or improvement in POP. The CNMAs suggested that PFMT may improve patient-reported POP between 0-6 months (n = 14 studies; Table 1) and objectively assessed POP (n = 14 studies), while PFMT and pessaries may improve patient-reported POP symptoms between 6-12 months (n = 14 studies; Table 2). PFMT, lifestyle advice, pessaries, hypopressive exercises, surgery and watchful waiting may improve quality of life. Results for ADLs and adverse events were narratively synthesised. It was unclear whether non-surgical interventions improved women’s ability to undertake ADLs (n = 4 studies). In general, across 24 studies the number of women experiencing adverse events from undertaking a non-surgical intervention for POP was low, but was higher for women who used pessaries.
Interpretation of results
Most of the evidence was rated as very low-certainty on both CINeMA and GRADE. Therefore, there is currently substantial uncertainty in the evidence base surrounding non-surgical interventions for POP.
Concluding message
PFMT may improve patient-reported symptoms of POP in the short-term, while pessaries may improve patient-reported and objectively-assessed POP in the short-term. However, there is a lack of longer-term data and the evidence supporting the results were highly uncertain. Future research should standardise outcome measures and focus on interventions and outcomes considered most important to women with lived experience of POP to facilitate future evidence syntheses.
Figure 1 Table 1: Network meta-analysis results for patient-reported cure or improvement in POP (short-term)
Figure 2 Table 2: Network meta-analysis results for patient-reported cure or improvement in POP (medium-term)
References
  1. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from www.cochrane.org/handbook.
Disclosures
Funding This research was funded by the National Institute of Health and Care Research (NIHR) Health Technology Assessment programme [grant number: NIHR161575]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Clinical Trial No Subjects None AI Not at all
07/06/2026 05:13:37